Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic profile of XK469 (2(R)-[4-(7-chloro-2-quinoxalinyl)oxyphenoxy]-propionic acid; NSC698215) in patients and in vitro: low potential for active or toxic metabolites or for drug-drug interactions.
Anderson LW, Collins JM, Klecker RW, Katki AG, Parchment RE, Boinpally RR, LoRusso PM, Ivy SP. Anderson LW, et al. Among authors: boinpally rr. Cancer Chemother Pharmacol. 2005 Oct;56(4):351-7. doi: 10.1007/s00280-004-0962-3. Epub 2005 May 13. Cancer Chemother Pharmacol. 2005. PMID: 15895233 Clinical Trial.
Phase II trial of fenretinide in advanced renal carcinoma.
Vaishampayan U, Heilbrun LK, Parchment RE, Jain V, Zwiebel J, Boinpally RR, LoRusso P, Hussain M. Vaishampayan U, et al. Among authors: boinpally rr. Invest New Drugs. 2005 Mar;23(2):179-85. doi: 10.1007/s10637-005-5864-7. Invest New Drugs. 2005. PMID: 15744595 Free article. Clinical Trial.
Iontophoresis of lecithin vesicles of cyclosporin A.
Boinpally RR, Zhou SL, Devraj G, Anne PK, Poondru S, Jasti BR. Boinpally RR, et al. Int J Pharm. 2004 Apr 15;274(1-2):185-90. doi: 10.1016/j.ijpharm.2004.01.016. Int J Pharm. 2004. PMID: 15072794
An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function.
O'Bryant CL, Haluska P, Rosen L, Ramanathan RK, Venugopal B, Leong S, Boinpally R, Franke A, Witt K, Evans J, Belani C, Gail Eckhardt S, Ramalingam S. O'Bryant CL, et al. Cancer Chemother Pharmacol. 2012 Mar;69(3):605-12. doi: 10.1007/s00280-011-1733-6. Epub 2011 Sep 22. Cancer Chemother Pharmacol. 2012. PMID: 21938545 Clinical Trial.
52 results